7 unchanged sentences
February 17, 2021
−Removed: Investment Agreement, dated as of February 9, 2021, between Pacific Biosciences of California, Inc.
−Removed: and SB Northstar LP
−Removed: February 10, 2021
−Removed: Form of Change in Control and Severance Agreement for executive officers
−Removed: February 26, 2021
−Removed: Amended Change in Control and Severance Agreement by and between the Registrant and Christian O.
−Removed: Henry dated February 3, 2021
−Removed: February 26, 2021
−Removed: Letter Relating to Employment Terms by and between the Registrant and Mark Van Oene effective January 8, 2021
−Removed: February 26, 2021
−Removed: Letter Relating to Employment Terms by and between the Registrant and Peter Fromen effective January 8, 2021
−Removed: February 26, 2021
Pacific Biosciences of California, Inc.
1 unchanged sentence
April 19, 2021
−Removed: Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated January 12, 2021
−Removed: February 26, 2021
+Added: Letter Relating to Employment Terms by and between the Registrant and Michele Farmer effective May 17, 2021
+Added: Filed herewith
+Added: Agreement and Plan of Merger and Plan of Reorganization among Pacific Biosciences of California, Inc., Apollo Acquisition Corp, Apollo Acquisition Sub, LLC, Omniome, Inc.
+Added: and Shareholder Representative Services, LLC, as securityholder representative, dated as of July 19, 2021
+Added: July 20, 2021
+Added: Securities Purchase Agreement, dated as of July 19, 2021, by and between Pacific Biosciences of California, Inc.
+Added: and each of the Investors
+Added: July 20, 2021
+Added: Registration Rights Agreement, dated as of July 19, 2021, by and between Pacific Biosciences of California, Inc.
+Added: and each of the Investors
+Added: July 20, 2021
+Added: Amendment to Development and Commercialization Agreement, dated as of June 3, 2021, by and between Pacific Biosciences of California, Inc.
+Added: and Invitae Corporation
+Added: Filed herewith
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
16 unchanged sentences
+ Indicates management contract or compensatory plan
+Added: ‡ Schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K.
+Added: The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request;
+Added: provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedules or exhibits so furnished.
† Certain confidential information contained in this Exhibit was omitted by means of marking such portions with brackets because the identified confidential information (i) is not material and (ii) would be competitively harmful if publicly disclosed.
3 unchanged sentences
P ACIFIC B IOSCIENCES OF C ALIFORNIA , I NC .
−Removed: /s/ S USAN G.
+Added: August 5, 2021
Chief Financial Officer
+Added: August 5, 2021
+Added: /s/ Michele Farmer
+Added: Michele Farmer
Vice President and Chief Accounting Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.